Olivia
Online
KJ Trades
@KimJTrades
Not a financial advisor. My posts do not mean buy or sell the stocks. Do your own due diligence beforehand. 10+ years trading full-time. Buying Dips
Joined May 2025
196 Following
3.1K Followers
217 Posts
Next week should get interesting
$BATL
$INDO
$SKYQ
$ANNA
$TURB
$PTLE
$TPET
$RBNE
$NINE
$MXC
$MARPS
$STAK
BREAKING: President Trump is preparing for a “fresh round” of US Military strikes on Iran, per CBS News.
President Trump and some members of the US Military and intelligence community canceled plans for the Memorial Day weekend in anticipation of possible strikes, CBS reports.
All the small oilers that were ripping when the Iran war started have round tripped. "IF" war resumes, some of these names are due for violent bounces. Here are a few tickers
$BATL
$INDO
$SKYQ
$ANNA
$TURB
$EONR
$TPET
$RBNE
$USEG
-trade them
-do not marry them.
$ALP = $ATON
$ATON at 31c is exactly the kind of microcap people laugh at near the lows and then chase way higher once the market wakes up.
Today’s PR is why.
ATON announced a ~$43M AI infrastructure + financing partnership tied to confidential compute / NVIDIA B300, while also highlighting GAMEE estimated Q1 revenue of $926K, up 56% YoY, with 5.57M users and 88.5M gameplays.
So this is not just random AI buzzwords.
You have:
AI infrastructure
GAMEE growth
Telegram ecosystem exposure
and a stock still priced like nobody believes any of it.
The part that really stands out:
some screeners show estimated net cash/share around $2.52 while the stock is trading around $0.31-$0.32.
That kind of disconnect can get violent if traders start paying attention.
Yes, screener data is not gospel.
Yes, dilution and execution risk are real.
Yes, this is speculative.
But that is also why the opportunity exists.
Tiny market cap.
Negative EV.
Big headline relative to company size.
Multiple catalysts hitting at once.
Still obscure.
Microcaps do not need perfect execution to rip.
They just need the market to realize the old valuation no longer makes sense.
$ATON feels like the kind of ugly, ignored setup that can deliver a serious dead-cat bounce at minimum, and a much bigger re-rate if management actually executes.
Disclosure: I am not a registered financial analyst or investment adviser. This is my opinion only, not financial advice. Do your own due diligence.
$FFAI 100%
$FFAI is getting so cheap that it honestly does not need a miracle to bounce.
It just needs traders to realize this thing is not fully dead yet.
This is not me calling it a clean long-term winner.
This is a dead cat bounce setup.
Why?
Recent PRs actually gave the market something to work with:
-Stockholders’ equity turned positive after debt optimization.
-The robotics side already started generating revenue and posted positive product gross margin in its first delivery quarter.
-Cumulative robotics shipments hit 22 units by the end of March.
-The company said paid robotics pre-orders topped 1,200 units.
-New PBB already has a 600-unit FX Super One pre-order tied to a non-refundable deposit.
-Management also rolled out a share-purchase style alignment program instead of just sitting there while the stock gets destroyed.
That does not remove the risks.
Dilution risk is real.
Execution risk is real.
Nasdaq/listing pressure is real.
This is still a highly speculative name.
But that is exactly why it can bounce.
When a stock gets this washed out, all it takes is:
1. a few decent PRs
2. a little volume
3. some small-cap momentum traders piling in
And suddenly a “dead” chart turns into a violent relief move.
$FFAI has EV + AI + robotics headlines, a brutally compressed price, and just enough fresh PR ammo to attract bounce players.
Not saying marry it.
I’m saying this is the type of broken, hated ticker that can rip hard on a dead cat bounce if momentum comes back.
High risk. Pure speculation. But definitely one to watch down here.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice.
$CUE
$CUE looks like the kind of sub-$0.20 setup that gets ignored right before sentiment flips.
Today’s PR was a real one.
Cue announced it will receive a $7.5M milestone payment from Boehringer Ingelheim after the first compound in the collaboration was selected and approved for lead optimization.
For a company that ended 2025 with $27.1M in cash, that is not a small update. It adds meaningful non-dilutive capital and, more importantly, it signals that a major pharma partner is still advancing the program.
That is the part the market may be underpricing.
This is still a high-risk biotech, but when you have:
a washed-out chart
a sub-$20M to $60M type valuation zone
partner validation from big pharma
fresh milestone cash
that is exactly the type of setup that can re-rate hard if momentum comes back.
$CUE does not need perfection from here.
It just needs the market to realize this story is not dead.
Sometimes the best upside comes from stocks everyone gave up on too early.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice. Please do your own due diligence and assess your own risk tolerance before making any investment decisions.
Weekly Recap
$CUE 20c - 67c highs
$FFAI 22c - 35c highs
$ATON 31c - Flat
$CUE looks like the kind of sub-$0.20 setup that gets ignored right before sentiment flips.
Today’s PR was a real one.
Cue announced it will receive a $7.5M milestone payment from Boehringer Ingelheim after the first compound in the collaboration was selected and approved for lead optimization.
For a company that ended 2025 with $27.1M in cash, that is not a small update. It adds meaningful non-dilutive capital and, more importantly, it signals that a major pharma partner is still advancing the program.
That is the part the market may be underpricing.
This is still a high-risk biotech, but when you have:
a washed-out chart
a sub-$20M to $60M type valuation zone
partner validation from big pharma
fresh milestone cash
that is exactly the type of setup that can re-rate hard if momentum comes back.
$CUE does not need perfection from here.
It just needs the market to realize this story is not dead.
Sometimes the best upside comes from stocks everyone gave up on too early.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice. Please do your own due diligence and assess your own risk tolerance before making any investment decisions.
$CUE $FFAI $ATON
$FFAI More bidders at open today. Dead cat bottom nailed 🏹
$FFAI is getting so cheap that it honestly does not need a miracle to bounce.
It just needs traders to realize this thing is not fully dead yet.
This is not me calling it a clean long-term winner.
This is a dead cat bounce setup.
Why?
Recent PRs actually gave the market something to work with:
-Stockholders’ equity turned positive after debt optimization.
-The robotics side already started generating revenue and posted positive product gross margin in its first delivery quarter.
-Cumulative robotics shipments hit 22 units by the end of March.
-The company said paid robotics pre-orders topped 1,200 units.
-New PBB already has a 600-unit FX Super One pre-order tied to a non-refundable deposit.
-Management also rolled out a share-purchase style alignment program instead of just sitting there while the stock gets destroyed.
That does not remove the risks.
Dilution risk is real.
Execution risk is real.
Nasdaq/listing pressure is real.
This is still a highly speculative name.
But that is exactly why it can bounce.
When a stock gets this washed out, all it takes is:
1. a few decent PRs
2. a little volume
3. some small-cap momentum traders piling in
And suddenly a “dead” chart turns into a violent relief move.
$FFAI has EV + AI + robotics headlines, a brutally compressed price, and just enough fresh PR ammo to attract bounce players.
Not saying marry it.
I’m saying this is the type of broken, hated ticker that can rip hard on a dead cat bounce if momentum comes back.
High risk. Pure speculation. But definitely one to watch down here.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice.
$CUE Volume cannot be ignored
$CUE looks like the kind of sub-$0.20 setup that gets ignored right before sentiment flips.
Today’s PR was a real one.
Cue announced it will receive a $7.5M milestone payment from Boehringer Ingelheim after the first compound in the collaboration was selected and approved for lead optimization.
For a company that ended 2025 with $27.1M in cash, that is not a small update. It adds meaningful non-dilutive capital and, more importantly, it signals that a major pharma partner is still advancing the program.
That is the part the market may be underpricing.
This is still a high-risk biotech, but when you have:
a washed-out chart
a sub-$20M to $60M type valuation zone
partner validation from big pharma
fresh milestone cash
that is exactly the type of setup that can re-rate hard if momentum comes back.
$CUE does not need perfection from here.
It just needs the market to realize this story is not dead.
Sometimes the best upside comes from stocks everyone gave up on too early.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice. Please do your own due diligence and assess your own risk tolerance before making any investment decisions.
$FFAI https://t.co/cOG2auDRDE Another PR. Feels like a bigger dead cat bounce is coming.
$FFAI is getting so cheap that it honestly does not need a miracle to bounce.
It just needs traders to realize this thing is not fully dead yet.
This is not me calling it a clean long-term winner.
This is a dead cat bounce setup.
Why?
Recent PRs actually gave the market something to work with:
-Stockholders’ equity turned positive after debt optimization.
-The robotics side already started generating revenue and posted positive product gross margin in its first delivery quarter.
-Cumulative robotics shipments hit 22 units by the end of March.
-The company said paid robotics pre-orders topped 1,200 units.
-New PBB already has a 600-unit FX Super One pre-order tied to a non-refundable deposit.
-Management also rolled out a share-purchase style alignment program instead of just sitting there while the stock gets destroyed.
That does not remove the risks.
Dilution risk is real.
Execution risk is real.
Nasdaq/listing pressure is real.
This is still a highly speculative name.
But that is exactly why it can bounce.
When a stock gets this washed out, all it takes is:
1. a few decent PRs
2. a little volume
3. some small-cap momentum traders piling in
And suddenly a “dead” chart turns into a violent relief move.
$FFAI has EV + AI + robotics headlines, a brutally compressed price, and just enough fresh PR ammo to attract bounce players.
Not saying marry it.
I’m saying this is the type of broken, hated ticker that can rip hard on a dead cat bounce if momentum comes back.
High risk. Pure speculation. But definitely one to watch down here.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice.
$ATON at 31c is exactly the kind of microcap people laugh at near the lows and then chase way higher once the market wakes up.
Today’s PR is why.
ATON announced a ~$43M AI infrastructure + financing partnership tied to confidential compute / NVIDIA B300, while also highlighting GAMEE estimated Q1 revenue of $926K, up 56% YoY, with 5.57M users and 88.5M gameplays.
So this is not just random AI buzzwords.
You have:
AI infrastructure
GAMEE growth
Telegram ecosystem exposure
and a stock still priced like nobody believes any of it.
The part that really stands out:
some screeners show estimated net cash/share around $2.52 while the stock is trading around $0.31-$0.32.
That kind of disconnect can get violent if traders start paying attention.
Yes, screener data is not gospel.
Yes, dilution and execution risk are real.
Yes, this is speculative.
But that is also why the opportunity exists.
Tiny market cap.
Negative EV.
Big headline relative to company size.
Multiple catalysts hitting at once.
Still obscure.
Microcaps do not need perfect execution to rip.
They just need the market to realize the old valuation no longer makes sense.
$ATON feels like the kind of ugly, ignored setup that can deliver a serious dead-cat bounce at minimum, and a much bigger re-rate if management actually executes.
Disclosure: I am not a registered financial analyst or investment adviser. This is my opinion only, not financial advice. Do your own due diligence.
$FFAI Catching bids
$FFAI is getting so cheap that it honestly does not need a miracle to bounce.
It just needs traders to realize this thing is not fully dead yet.
This is not me calling it a clean long-term winner.
This is a dead cat bounce setup.
Why?
Recent PRs actually gave the market something to work with:
-Stockholders’ equity turned positive after debt optimization.
-The robotics side already started generating revenue and posted positive product gross margin in its first delivery quarter.
-Cumulative robotics shipments hit 22 units by the end of March.
-The company said paid robotics pre-orders topped 1,200 units.
-New PBB already has a 600-unit FX Super One pre-order tied to a non-refundable deposit.
-Management also rolled out a share-purchase style alignment program instead of just sitting there while the stock gets destroyed.
That does not remove the risks.
Dilution risk is real.
Execution risk is real.
Nasdaq/listing pressure is real.
This is still a highly speculative name.
But that is exactly why it can bounce.
When a stock gets this washed out, all it takes is:
1. a few decent PRs
2. a little volume
3. some small-cap momentum traders piling in
And suddenly a “dead” chart turns into a violent relief move.
$FFAI has EV + AI + robotics headlines, a brutally compressed price, and just enough fresh PR ammo to attract bounce players.
Not saying marry it.
I’m saying this is the type of broken, hated ticker that can rip hard on a dead cat bounce if momentum comes back.
High risk. Pure speculation. But definitely one to watch down here.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice.
$CUE Inside candle being put in today on the daily. Still no RS risk rest of this week.
$CUE looks like the kind of sub-$0.20 setup that gets ignored right before sentiment flips.
Today’s PR was a real one.
Cue announced it will receive a $7.5M milestone payment from Boehringer Ingelheim after the first compound in the collaboration was selected and approved for lead optimization.
For a company that ended 2025 with $27.1M in cash, that is not a small update. It adds meaningful non-dilutive capital and, more importantly, it signals that a major pharma partner is still advancing the program.
That is the part the market may be underpricing.
This is still a high-risk biotech, but when you have:
a washed-out chart
a sub-$20M to $60M type valuation zone
partner validation from big pharma
fresh milestone cash
that is exactly the type of setup that can re-rate hard if momentum comes back.
$CUE does not need perfection from here.
It just needs the market to realize this story is not dead.
Sometimes the best upside comes from stocks everyone gave up on too early.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice. Please do your own due diligence and assess your own risk tolerance before making any investment decisions.
$FFAI is getting so cheap that it honestly does not need a miracle to bounce.
It just needs traders to realize this thing is not fully dead yet.
This is not me calling it a clean long-term winner.
This is a dead cat bounce setup.
Why?
Recent PRs actually gave the market something to work with:
-Stockholders’ equity turned positive after debt optimization.
-The robotics side already started generating revenue and posted positive product gross margin in its first delivery quarter.
-Cumulative robotics shipments hit 22 units by the end of March.
-The company said paid robotics pre-orders topped 1,200 units.
-New PBB already has a 600-unit FX Super One pre-order tied to a non-refundable deposit.
-Management also rolled out a share-purchase style alignment program instead of just sitting there while the stock gets destroyed.
That does not remove the risks.
Dilution risk is real.
Execution risk is real.
Nasdaq/listing pressure is real.
This is still a highly speculative name.
But that is exactly why it can bounce.
When a stock gets this washed out, all it takes is:
1. a few decent PRs
2. a little volume
3. some small-cap momentum traders piling in
And suddenly a “dead” chart turns into a violent relief move.
$FFAI has EV + AI + robotics headlines, a brutally compressed price, and just enough fresh PR ammo to attract bounce players.
Not saying marry it.
I’m saying this is the type of broken, hated ticker that can rip hard on a dead cat bounce if momentum comes back.
High risk. Pure speculation. But definitely one to watch down here.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice.
$CUE Look left….
$CUE No RS risk this week - Meeting on April 13th to vote on RS but if this can climb over dollar on its own then it won’t need RS at all.
$CUE looks like the kind of sub-$0.20 setup that gets ignored right before sentiment flips.
Today’s PR was a real one.
Cue announced it will receive a $7.5M milestone payment from Boehringer Ingelheim after the first compound in the collaboration was selected and approved for lead optimization.
For a company that ended 2025 with $27.1M in cash, that is not a small update. It adds meaningful non-dilutive capital and, more importantly, it signals that a major pharma partner is still advancing the program.
That is the part the market may be underpricing.
This is still a high-risk biotech, but when you have:
a washed-out chart
a sub-$20M to $60M type valuation zone
partner validation from big pharma
fresh milestone cash
that is exactly the type of setup that can re-rate hard if momentum comes back.
$CUE does not need perfection from here.
It just needs the market to realize this story is not dead.
Sometimes the best upside comes from stocks everyone gave up on too early.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice. Please do your own due diligence and assess your own risk tolerance before making any investment decisions.
$CUE looks like the kind of sub-$0.20 setup that gets ignored right before sentiment flips.
Today’s PR was a real one.
Cue announced it will receive a $7.5M milestone payment from Boehringer Ingelheim after the first compound in the collaboration was selected and approved for lead optimization.
For a company that ended 2025 with $27.1M in cash, that is not a small update. It adds meaningful non-dilutive capital and, more importantly, it signals that a major pharma partner is still advancing the program.
That is the part the market may be underpricing.
This is still a high-risk biotech, but when you have:
a washed-out chart
a sub-$20M to $60M type valuation zone
partner validation from big pharma
fresh milestone cash
that is exactly the type of setup that can re-rate hard if momentum comes back.
$CUE does not need perfection from here.
It just needs the market to realize this story is not dead.
Sometimes the best upside comes from stocks everyone gave up on too early.
Disclosure: I am not a registered financial analyst or investment adviser. This post reflects my personal opinion only and is not financial advice. Please do your own due diligence and assess your own risk tolerance before making any investment decisions.
Markets don’t bottom when $VIX is up and the S&P is down.
That’s just stress.
Real bottoms happen when:
• S&P makes new lows
• VIX doesn’t
• Bad news stops working
Bottoms are about exhaustion, not fear.
When S&P is falling and $VIX is rising, the market is still discovering risk.
People are actively buying protection. That means fear is growing, not finished.
A bottom can’t form while:
•New sellers are still showing up
•Hedgers are still willing to pay up
•Volatility is still being bid
That’s an unfinished process.
Last Seen Users on Sotwe
🤤 அசுரன் 🤤
Seen from India
Ali Brand
Seen from Malaysia
Milf Weakness {^6K^}
Seen from Turkey
فـراشه
Seen from Germany
Mixtinction
Seen from Malaysia
quandaitran
Seen from Vietnam
Bokep hot
Seen from Singapore
Gostosos Da Rua
Seen from Portugal
Papa Muda / AKI TOLOHEOR
Seen from Indonesia
Aubrey 🏳️⚧️
Seen from United States
Most Popular Users
Elon Musk
@elonmusk
241.5M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.8M followers
Taylor Swift
@taylorswift13
83.7M followers
Lady Gaga
@ladygaga
75.2M followers
Virat Kohli
@imvkohli
73M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers